= Adaptive Perfusion: A Novel In Vitro Drug Release Testing Method for Complex Drug Products by the FDA
{c}
Official technical account: https://www.fda.gov/science-research/licensing-and-collaboration-opportunities/adaptive-perfusion-novel-in-vitro-drug-release-testing-method-complex-drug-products . Technology Summary defines in-vitro release testing and describes pressure-driven tangential-flow filtration as an alternative to rate-limiting passive dialysis-membrane transport. Development Stage identifies in-vitro data and a prototype. The account links the primary 2021 Journal of Controlled Release paper, PMID 33766693.
Back to article page
